• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dialysis Centers Included in Plan to Expand Access to COVID-19 Vaccines


The announcement allowing the administration of COVID-19 vaccines in dialysis centers is part of a larger $10 billion investment, largely funded by the American Rescue Plan, to expand access.

The Biden administration announced Thursday that dialysis centers will be permitted to administer vaccinations against the virus that causes COVID-19, in an effort to protect a population at high risk of severe illness or death from the disease.

The industry had been lobbying for the change.

The announcement is part of a nearly $10 billion investment largely funded by the American Rescue Plan to expand access to vaccines, the White House said. A total of $6 billion will go to community health centers in underserved areas; $3 billion will go to states, territories, and large urban areas for programs to increase vaccine access, acceptance, and uptake.

Another $350 million will fund community health workers.

“People on dialysis who contract COVID-19 often have severe adverse health outcomes—half require hospitalization and 20% to 30% die from COVID-19,” CDC Director Rochelle P. Walensky, MD, MPH, said in a statement. In her statement, she also noted the health disparities that affect non-White patients with chronic kidney disease (CKD), noting that advanced CKD affects Blacks, Hispanics, and American Indians/Alaska Natives (AI/AN) at higher rates; they are also less likely to receive a kidney transplant and to receive dialysis treatments long term.

COVID-19 also affects these populations at higher rates and in unequal ways, with Blacks, Hispanics, and AI/AN at least twice as likely to die from COVID-19 than Whites.

Providing vaccines in dialysis centers where patients are used to going to receive usual care could improve uptake, the operators of the centers said. More than 550,000 individuals receive dialysis treatments annually through the Medicare End-Stage Renal Disease Program.

"Offering patients direct access to the vaccine in a convenient and trusted site of care improves health equity, addresses challenges with third-party sites and reduces hesitancy rates," Javier Rodriguez, DaVita's CEO, said in a statement.

Last week, US Renal Care, another dialysis provider, said its centers that are administering the vaccine have an average patient vaccination rate of 45%, compared with an overall population of vaccinated patients of 16%.

Walensky also said vaccines will also be available to center health care workers. She said just 35% of staff in dialysis centers have been vaccinated.

Related Videos
Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions
dr kimberly maxfield
Amal Trivedi, MD
Ted Okon, MBA, Community Oncology Alliance
Lalan Wilfongd, MD, US Oncology Network
Allister Chang, co-founder, Fabric Health
Mike Koroscik, MBA, MHA, vice president of oncology, Allina Health and the Allina Health Cancer Institute
Margaret Liang, MD, MSHPM, gynecologic oncologist and health services researcher, program director for the gynecologic oncology fellowship program, Cedars-Sinai Medical Center, Cedars-Sinai Cancer Center
Kathy Oubre, MS, CEO, Pontchartrain Cancer Center
Jennifer Sturgill, DO, Central Ohio Primary Care
Related Content
© 2023 MJH Life Sciences
All rights reserved.